Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation

OBJECTIVE: Tyloxapol is a non-ionic surfactant with diverse pharmacological effects including anti-inflammatory, anti-malignant tumor and antioxidant activities. However, the effect of tyloxapol on osteoclastogenesis has not been elucidated. In this study, we intended to clarify the effect of tyloxa...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wen, Li, Haijun, Lou, Yan, Zhang, Yue, Wang, Jia, Qian, Ming, Wei, Haifeng, Xiao, Jianru, Xu, Youjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063697/
https://www.ncbi.nlm.nih.gov/pubmed/33981577
http://dx.doi.org/10.1016/j.jot.2021.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063697/
https://www.ncbi.nlm.nih.gov/pubmed/33981577
http://dx.doi.org/10.1016/j.jot.2021.01.005

Ejemplares similares